Surgical management of pancreatic cancer has improved, leading to better patient outcomes and survival rates.

• Five-year survival rates for pancreatic ductal adenocarcinoma have risen from under 5% to about 13%.
• Enhanced perioperative management and new scoring systems have reduced postoperative mortality.

Centralizing care in dedicated pancreas units is crucial for optimal treatment, particularly for complex cases involving borderline-resectable tumors.

• Adoption of minimally invasive approaches, including robotic techniques, is on the rise but requires expertise and experience to maximize benefits.